<DOC>
	<DOCNO>NCT00321074</DOCNO>
	<brief_summary>The purpose study compare safety efficacy two different tacrolimus base immunosuppressive regimen , one combination daclizumab , combination steroid , recipient suboptimal liver . Pharmacokinetics tacrolimus bile composition measure subgroup patient .</brief_summary>
	<brief_title>Tacrolimus Daclizumab Versus Tacrolimus Steroids Liver Recipients Receiving Sub-optimal Grafts</brief_title>
	<detailed_description>Open , multicentre , 1:1 randomise , parallel group phase III study compare safety efficacy tacrolimus ( FK506 ) monoclonal anti-IL2R antibody ( daclizumab ) v tacrolimus ( FK506 ) steroid evaluate pharmacokinetics liver allograft recipient receive suboptimal liver . Patients receive primary suboptimal liver allograft transplantation ( donor &gt; 65 year and/or liver macrosteatosis &gt; 15 % ) randomise one follow treatment arm : Group I : steroid bolus ( intraoperative ) monoclonal anti-IL2R antibody ( daclizumab ) induction tacrolimus Group II : steroid bolus ( intraoperative ) tacrolimus steroid</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Daclizumab</mesh_term>
	<criteria>Signed informed consent Adult patient schedule receive liver transplant Donors old 65 and/or liver macrosteatosis &gt; 15 % Female patient childbearing potential agree maintain effective birth control study must negative pregnancy test baseline Patient previously receive receive organ transplant liver , liver retransplantation . Patient significant , uncontrolled concomitant infection and/or severe diarrhea , vomit , active peptic ulcer Patient receive auxiliary graft bioartificial liver use . Any pathology medical condition interfere protocol study proposal Other exclusion applies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>IMMUNOSUPPRESSION</keyword>
	<keyword>TACROLIMUS</keyword>
	<keyword>MARGINAL LIVERS</keyword>
	<keyword>PHARMACOKINETICS</keyword>
</DOC>